Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT05673590 · UNKNOWN
Trial details
- NCT number
- NCT05673590
- Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-12
- Primary completion
- 2025-06-15
- Enrollment
- 612
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.